PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: The Beacon Company

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

GreenWood, Inc. Reaches 4 Million Safe Work Hours at Merck Project - No lost time accident in 21 years of continuous service
GreenWood, Inc. Reaches 4 Million Safe Work Hours at Merck Project

 

NewswireToday - /newswire/ - Greenville, SC, United States, 2011/03/22 - No lost time accident in 21 years of continuous service.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

GreenWood, Inc., an integrated operations, maintenance and construction solutions provider, recently achieved 4 million safe work hours without a lost time accident at the Merck project in Elkton, Virginia. Since 1990, GreenWood has continuously provided supplemental maintenance and capital construction support services for this pharmaceutical manufacturing site. Safety is the company’s number one priority and is instilled in the entire work force from management to all project personnel and has resulted in helping GreenWood achieve this significant milestone.

“This is an important accomplishment and we are proud of our team for always placing safety as the highest priority in all of our work,” says Brad Wood, President of GreenWood, Inc. “A safety milestone of this magnitude requires teamwork, solid communications, job preparation, and a constant focus on executing the work safely every day. The opportunity to provide our services for over 21 years for a company of Merck’s caliber is a privilege and we are grateful in being able to help support their position as a leading global health care provider.”

The Merck site in Elkton, Virginia is one of the company’s worldwide manufacturing facilities that contribute to the company’s broad portfolio of prescription medicines, vaccines, consumer care and animal health products. GreenWood, Inc. has maintained an on-going presence at this site since 1990.

About GreenWood, Inc.

GreenWood (GreenWoodInc.com) provides integrated maintenance, operations and construction solutions designed to extend the life of critical assets, influence operational efficiencies and deliver bottom line improvements for plants and facilities throughout the Southeast and Mid-Atlantic. We operate under a “Customer-Centered” philosophy where safety performance is always first and our flexibility to respond to customer needs is an ongoing priority.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: The Beacon Company

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


GreenWood, Inc. Reaches 4 Million Safe Work Hours at Merck Project

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: William Russell - TheBeaconCompany.com 
864-331-0447 wrussell[.]thebeaconcompany.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any The Beacon Company securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From The Beacon Company / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe
FDA Grants Priority Review to Genentech’s Lucentis® (Ranibizumab Injection) Supplemental Biologics License Application
Genentech’s TECENTRIQ® (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  Triggr & Bloom





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)